The Role of Phosphodiesterase Inhibitors in Incretin Secretion

NCT02363335 · PHASE1 · COMPLETED · Sponsor: National Institute on Aging (NIA) · Conditions: Healthy

By Priya Raman · Science Reporter

Nov 9 07:00 ETSource: ClinicalTrials.gov

From the source

The Role of Phosphodiesterase Inhibitors in Incretin Secretion
NCT02363335 · PHASE1 · COMPLETED · Sponsor: National Institute on Aging (NIA) · Conditions: Healthy Volunteers.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT02363335